UPMC-WESTERN MARYLAND CORP — History
CCN 210027 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$312M
Latest Revenue (FY2022)
-6.2%
Revenue CAGR (3yr)
-12.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $355M | $357M | $312M | -12.6% | -6.2% |
| Operating Expenses | $336M | $343M | $350M | +1.9% | +2.1% |
| Operating Margin | 5.4% | 3.9% | -12.1% | -406.7% | +0.0% |
| Net Income | $19M | $14M | $-38M | -368.1% | +0.0% |
| Licensed Beds | 191 | 191 | 200 | +4.7% | +2.3% |
| Total Patient Days | 49,450 | 49,806 | 46,903 | -5.8% | -2.6% |
| Medicare Day % | 71% | 60% | 57% | -4.5% | -9.9% |
| Medicaid Day % | 21% | 19% | 21% | +11.4% | -0.1% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -11.9% ($355M → $312M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-6.2%
This Hospital
+7.6%
State Avg
Latest Margin
-12.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $291M | -20.8% |
| FY2024 (proj) | $270M | -29.5% |
| FY2025 (proj) | $249M | -38.3% |